Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer [NA]
Clinical trial update evaluating ultrasound for detecting taxane-induced neuropathy in breast cancer patients has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2024-04-05Clinical Trial Update: Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer [Phase 2]
A Phase 2 trial evaluated two ribociclib dose levels in combination with aromatase inhibitors for HR-positive, HER2-negative advanced breast…
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Radiologic Evaluation and Breast Density (READ) [NA]
Completed clinical trial with radiologic evaluation and breast density data in breast cancer patients; results posted.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: Evaluate the Effectiveness and Toxicity of Adjuvant Ultra-hypofractionated Radiotherapy for Breast Cancer [Phase 2]
A Phase 2 trial assessing the effectiveness and toxicity of adjuvant ultra-hypofractionated radiotherapy in female breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity [Phase 2]
Phase 2 clinical trial exploring a potential protective role of SGLT-2 inhibitors against chemotherapy-induced cardiotoxicity in breast canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 [Phase 3]
Phase 3 trial update for neoadjuvant chemotherapy in HER2-positive breast cancer (TRAIN-2) is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC [Phase 1]
Phase 1 dose-escalation study of MORAb-066 targeting tissue factor-expressing malignancies, including breast, pancreatic, colorectal, and no…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments [Phase 2]
A Phase 2 study assessing alpelisib with either fulvestrant or letrozole in PIK3CA-mutant, HR+, HER2-negative advanced breast cancer that pr…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Effects of Exemestane on Bone Strength
A completed clinical trial assessing the effects of exemestane on bone strength in patients with osteoporosis and breast cancer; results pos…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer [Phase 1, Phase 2]
Clinical trial update for HCQ+ADC vs ADC in advanced/metastatic breast cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY [Phase 3]
A Phase 3 trial evaluating palbociclib combined with tamoxifen for HR-positive, HER2-negative advanced breast cancer in Asian women is repor…
-
CLINICAL_TRIALS trial_result · 2024-03-22Clinical Trial Update: A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer [Phase 1]
An early-phase study evaluating H3B-6545 in combination with palbociclib for advanced or metastatic estrogen receptor-positive, HER2-negativ…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer [Phase 3]
Phase 3 clinical trial investigating electroacupuncture plus a four-drug antiemetic regimen (including olanzapine) for chemotherapy-induced …
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: A Study of TAS-120 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study of futibatinib (TAS-120) in patients with advanced solid tumors, including cholangiocarcinoma, urothelial carcinoma, breas…
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer [Phase 3]
Phase 3 trial assessing reduced-dose pegfilgrastim as support for chemotherapy in breast cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Phase 3]
Phase 3 trial comparing tamoxifen to anastrozole, alone or with zoledronic acid in breast cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy [Phase 3]
Phase 3 clinical trial evaluating capecitabine plus camrelizumab for non-pCR triple-negative breast cancer with tumor-infiltrating lymphocyt…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients" [Phase 2]
Phase 2 clinical trial evaluating adding pentoxifylline to neoadjuvant chemotherapy in breast cancer patients; status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies [Phase 2]
Phase 2 trial of poziotinib in EGFR or HER2 activating mutations across advanced malignancies was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer [Phase 3]
A Phase 3 trial evaluating nivolumab with neoadjuvant chemotherapy and adjuvant endocrine therapy versus placebo in high-risk ER-positive, H…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Trilaciclib, a CDK4/6 Inhibitor, in Patients With Early-Stage Triple Negative Breast Cancer [Phase 2]
Phase 2 trial update for trilaciclib in early-stage triple-negative breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating ipatasertib plus paclitaxel in PI3K/AKT/PTEN-altered locally advanced or metastatic triple-negative breast cancer o…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES) [Phase 3]
Phase 3 clinical trial evaluating dalpiciclib with endocrine therapy for advanced breast cancer after failure of CDK4/6 inhibitors is curren…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy [NA]
Clinical trial update on supine MRI in breast cancer patients undergoing upfront surgery or neoadjuvant therapy; study completed with result…
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Dexamethasone Versus Dexmedetomidine as Adjuncts to Serratus Anterior Plane Block [Phase 4]
Phase 4 trial comparing dexamethasone versus dexmedetomidine as adjuncts to serratus anterior plane block for breast cancer treatment contex…